Search Tag: Valo Therapeutics
2022 27 Jun
Valo Therapeutics Oy, the developer of novel, adaptable immunotherapy platforms for cancer and infectious diseases announced the appointment of an accomplished life sciences executive. Anthony Giovinazzo will bring his considerable track record of capital raising, drug development, and company leadership in North America to the company’s Board of Directors....Read more
2022 16 Jun
Valo Therapeutics Oy, the developer of novel, adaptable immunotherapy platforms for cancer and infectious diseases announced the appointment of Dr Hemanshu Shah as Chief Business Officer (CBO), based in the US. ValoTx’s CEO, Paul Higham, said, “I am delighted to welcome Dr Hemanshu Shah as our CBO. Hemanshu brings a wealth of business development...Read more